PLCG2 and cancer: We have recently shown that PL potently inhibits STAT3 activation in cancer cells [19] and that STAT3 non-transcriptionally regulates collagen-induced platelet activation/aggregation by facilitating an interaction between the kinase Syk and the substrate PLCγ2 [22].